rs1553396458
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001615.4(ACTG2):c.632G>A(p.Arg211Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000139 in 1,440,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
ACTG2
NM_001615.4 missense
NM_001615.4 missense
Scores
13
4
1
Clinical Significance
Conservation
PhyloP100: 9.96
Genes affected
ACTG2 (HGNC:145): (actin gamma 2, smooth muscle) Actins are highly conserved proteins that are involved in various types of cell motility and in the maintenance of the cytoskeleton. Three types of actins, alpha, beta and gamma, have been identified in vertebrates. Alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. This gene encodes actin gamma 2; a smooth muscle actin found in enteric tissues. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Based on similarity to peptide cleavage of related actins, the mature protein of this gene is formed by removal of two N-terminal peptides.[provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ACTG2. . Gene score misZ 3.3487 (greater than the threshold 3.09). Trascript score misZ 4.3482 (greater than threshold 3.09). GenCC has associacion of gene with visceral myopathy 1, familial visceral myopathy, megacystis-microcolon-intestinal hypoperistalsis syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.923
PP5
Variant 2-73914698-G-A is Pathogenic according to our data. Variant chr2-73914698-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 495145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-73914698-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTG2 | NM_001615.4 | c.632G>A | p.Arg211Gln | missense_variant | 7/9 | ENST00000345517.8 | NP_001606.1 | |
ACTG2 | NM_001199893.2 | c.503G>A | p.Arg168Gln | missense_variant | 6/8 | NP_001186822.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTG2 | ENST00000345517.8 | c.632G>A | p.Arg211Gln | missense_variant | 7/9 | 1 | NM_001615.4 | ENSP00000295137.3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome AF: 0.00000139 AC: 2AN: 1440226Hom.: 0 Cov.: 31 AF XY: 0.00000140 AC XY: 1AN XY: 715836
GnomAD4 exome
AF:
AC:
2
AN:
1440226
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
715836
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3Uncertain:1Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Visceral myopathy 1 Pathogenic:2Other:1
Pathogenic, no assertion criteria provided | case-control | Wangler Lab, Baylor College of Medicine | Oct 04, 2019 | Identified as a de novo event in our clinical cohort of MMIHS - |
not provided, no classification provided | literature only | GeneReviews | - | Insufficient data for genotype-phenotype correlations - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Human Genetics, Inc, Center for Human Genetics, Inc | Oct 17, 2016 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 01, 2024 | Identified in two individuals from the same family with CIPO or MMIHS (PMID: 29387497); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29387497) - |
ACTG2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 28, 2023 | The ACTG2 c.632G>A variant is predicted to result in the amino acid substitution p.Arg211Gln. This variant was reported in an individual with megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) (Table S2 and S3, ID FAM53-1 or Fam53, maternally-inherited, Assia Batzir et al. 2019. PubMed ID: 31769566) and was also reported in an individual with chronic intestinal pseudoobstruction and in her fetus with MMIHS (Whittington et al. 2017. PubMed ID: 29387497). This variant has not been reported in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
.;D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
.;M;M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Pathogenic
Sift4G
Uncertain
D;D;D
Polyphen
1.0
.;D;D
Vest4
MutPred
0.72
.;Gain of ubiquitination at K216 (P = 0.0635);Gain of ubiquitination at K216 (P = 0.0635);
MVP
MPC
2.3
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at